Huldrych F Günthard

发表

Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver

Astrid Gall, Jacques Fellay, Oliver Laeyendecker, 2018, Virus evolution.

Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.

Amalio Telenti, Hansjakob Furrer, Manuel Battegay, 2002, AIDS.

The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.

Jacques Fellay, Amalio Telenti, Hansjakob Furrer, 2008, The Journal of infectious diseases.

Stable virulence levels in the HIV epidemic of Switzerland over two decades

Sebastian Bonhoeffer, Amalio Telenti, Hansjakob Furrer, 2006, AIDS.

Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel

Amalio Telenti, Giuliano Rizzardini, Huldrych F Günthard, 2010 .

Update of the drug resistance mutations in HIV-1: Spring 2008.

Huldrych F Günthard, Deenan Pillay, Victoria A Johnson, 2008, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.

Matthias Cavassini, Patrick Taffé, Sebastian Bonhoeffer, 2010, The Journal of infectious diseases.

Cohort profile: the Swiss HIV Cohort study.

Amalio Telenti, Hansjakob Furrer, Sabine Yerly, 2010, International journal of epidemiology.

Estimating the basic reproductive number from viral sequence data.

Beda Joos, Tanja Stadler, Sebastian Bonhoeffer, 2012, Molecular biology and evolution.

Can directionality of HIV transmission be predicted by next generation sequencing data?

Huldrych F Günthard, H. Günthard, R. Kouyos, 2018, The Journal of infectious diseases.

Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1

Tanja Stadler, David A Stephens, Huldrych F Günthard, 2016, PloS one.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Jennifer F Hoy, Michael S Saag, Huldrych F Günthard, 2016, JAMA.

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey

Jörg Schüpbach, Sabine Yerly, Jürg Böni, 2007, AIDS.

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Sabine Yerly, Huldrych F Günthard, Deenan Pillay, 2009, The Lancet. Infectious diseases.

2015 Update of the Drug Resistance Mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2015, Topics in antiviral medicine.

Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance

Jacques Fellay, Dermot Kelleher, Amalio Telenti, 2011, Hepatology.

Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.

Bernard Hirschel, Huldrych F Günthard, John Frater, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Jacques Fellay, Amalio Telenti, Huldrych F Günthard, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.

Matthias Cavassini, Amalio Telenti, Hansjakob Furrer, 2011, The Journal of infectious diseases.

HIV replication elicits little cytopathic effects in vivo: Analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death

Beda Joos, Sebastian Bonhoeffer, Huldrych F Günthard, 2006, Journal of medical virology.

Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol.

Beda Joos, Sebastian Bonhoeffer, Huldrych F Günthard, 2004, Virology.

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

David Dunn, Kholoud Porter, Rodolphe Thiébaut, 2011, The Lancet. Infectious diseases.

The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection

Bernard Hirschel, Sabine Yerly, Huldrych F Günthard, 2009, AIDS.

Simultaneously estimating evolutionary history and repeated traits phylogenetic signal: applications to viral and host phenotypic evolution

Trevor Bedford, Marc A Suchard, Andrew Rambaut, 2015, Methods in ecology and evolution.

2011 update of the drug resistance mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2011, Topics in antiviral medicine.

A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control

David Heckerman, Jacques Fellay, Christoph Lippert, 2013, eLife.

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

Sven Bergmann, Thomas Berg, Zoltán Kutalik, 2010, Gastroenterology.

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

Jennifer F Hoy, Amalio Telenti, Michael S Saag, 2014, JAMA.

Glancing behind virus load variation in HIV-1 infection.

Sebastian Bonhoeffer, Huldrych F Günthard, Marek Fischer, 2003, Trends in microbiology.

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.

Matthias Cavassini, Sabine Yerly, Huldrych F Günthard, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.